| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/22/2011 | US20110229513 LPS Based Vaccines |
| 09/22/2011 | US20110229509 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 09/22/2011 | US20110229508 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 09/22/2011 | US20110229504 Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| 09/22/2011 | US20110229481 Cancer-associated antigen analogue peptides and uses thereof |
| 09/22/2011 | US20110229478 Erbb3 based methods and compositions for treating neoplasms |
| 09/22/2011 | US20110229475 Novel compounds |
| 09/22/2011 | US20110229466 Vascular endothelial growth factor 2 |
| 09/22/2011 | US20110229461 PD-1 Antibodies |
| 09/22/2011 | US20110229458 Methods for selecting protease resistant polypeptides |
| 09/22/2011 | CA2793671A1 Bmp-2 peptides & methods of use |
| 09/22/2011 | CA2793309A1 Method of producing transcripts using cryptic splice sites |
| 09/22/2011 | CA2792476A1 Production of proteins and polypeptides |
| 09/21/2011 | EP2366784A1 Construction and crystallization of expression system for rna polymerase pb1-pb2 protein derived from influenza virus |
| 09/21/2011 | EP2366719A2 Process of production of a recombinant polypeptide by fusion with an autoprotease |
| 09/21/2011 | EP2366713A2 Polypeptide variants with altered effector function |
| 09/21/2011 | EP2366712A2 A tumor suppressor designated TS10Q23.3 |
| 09/21/2011 | EP2365982A1 Peptide synthesis using enzymatic activation and coupling |
| 09/21/2011 | EP2076529B1 Antibacterial and antiviral peptides from actinomadura namibiensis |
| 09/21/2011 | EP1604015B1 METHOD FOR PRODUCING TARGET PROTEINS BY DELETING OR AMPLIFYING ibpA AND/OR ibpB GENE CODING FOR INCLUSION BODY-ASSOCIATED PROTEINS |
| 09/21/2011 | EP1519956B1 Epha2 monoclonal antibodies and methods of use thereof |
| 09/21/2011 | EP1507003B1 Process for producing protein in cell-free protein synthesis system using thioredoxin fused protein expression vector |
| 09/21/2011 | EP1492811B1 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 09/21/2011 | EP1487428B1 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 09/21/2011 | EP0871474B2 Generation of human insulin |
| 09/21/2011 | CN201981206U 一种鱼蛋白智能提取装置 Kind of fish protein intelligent extraction device |
| 09/21/2011 | CN1952129B Angptl4 deletion mutant and application thereof |
| 09/21/2011 | CN1894278B Akt activity specifically inhibiting polypeptide |
| 09/21/2011 | CN1718735B Production of polyglutamic acid using na bean bacillus solid fermentation and its product application |
| 09/21/2011 | CN102197047A Mutant delta5 desaturases and their use in making polyunsaturated fatty acids |
| 09/21/2011 | CN102191306A Enzymatic preparation method for antihypertensive peptides from jellyfish |
| 09/21/2011 | CN102191305A Preparation method of hoof nail polypeptide through composite hydrolysis |
| 09/21/2011 | CN102191304A Porcine plasma antioxidant peptide |
| 09/21/2011 | CN102191303A Method for expressing and preparing gene recombinant Talpha1 |
| 09/21/2011 | CN102191275A Method to enhance cell viability and biologic product yield |
| 09/21/2011 | CN102191256A Hypha mycin gene and karyogamy gene-engineering bacteria thereof |
| 09/21/2011 | CN102191255A Preparation and application of recombinant plectasin |
| 09/21/2011 | CN102191207A Gene engineering bacterium of expression of soluble FGF-21 and construction method and application thereof |
| 09/21/2011 | CN102191194A Bacillus subtilis and antibacterial protein thereof |
| 09/21/2011 | CN102190732A PGBD-2 fusion defensin, and preparation method and application thereof |
| 09/21/2011 | CN102190720A Method for preparing human glucagon-like peptide-2 (1-35 peptide) analogue |
| 09/21/2011 | CN102190706A Novel loach protein antihypertensive peptide and preparation method thereof |
| 09/21/2011 | CN102188332A Cosmetic containing oceanic shellfish active peptide and preparation method and application thereof |
| 09/21/2011 | CN101705233B Recombinant human herpes simplex virus I protein HSV I gG and application thereof |
| 09/21/2011 | CN101353686B Production method of haemachrome and decolorizing blood plasma albumen powder |
| 09/21/2011 | CN101153310B Method for producing anti-hypertension peptide with complex zymohydrolysis of hairtail backbone |
| 09/20/2011 | US8022177 Peptides and calcium regulation in mammalian cells |
| 09/20/2011 | US8022174 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof |
| 09/20/2011 | US8021881 Medium for the protein-free and serum-free cultivation of cells |
| 09/20/2011 | US8021879 Adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof |
| 09/20/2011 | US8021878 Regulatory switches for controlling insect development; biological pest control |
| 09/20/2011 | US8021874 Very long chain polyunsaturated fatty acids, methods of production, and uses |
| 09/20/2011 | US8021867 Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity |
| 09/20/2011 | US8021862 Process for preparing human G-CSF |
| 09/20/2011 | US8021861 Pathogenic Escherichia coli associated protein |
| 09/20/2011 | US8021860 Method for producing human antibodies to a self physiological receptor by site-directed in vitro immunization of human lymphocytes |
| 09/20/2011 | US8021859 Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells |
| 09/20/2011 | US8021858 Method for making polyalkylene oxide modified hemoglobin |
| 09/20/2011 | US8021857 Glyphosate-N-acetyltransferase (GAT) genes |
| 09/20/2011 | US8021856 Transgenic cell for use as bioreactor in production of human estrogen receptor (HER) specific monoclonal antibody for use in targeted destruction of tumor cells |
| 09/20/2011 | US8021662 Microorganisms for therapy |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | CA2473686C Novel cytokine zcytor17 ligand |
| 09/20/2011 | CA2400562C Hybrid expression of neisserial proteins |
| 09/20/2011 | CA2376485C Recombinant anti-cd40 antibody and uses thereof |
| 09/20/2011 | CA2369848C Human endogenous retrovirus in breast cancer |
| 09/20/2011 | CA2337100C Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same |
| 09/20/2011 | CA2329137C Novel tumor antigen useful in diagnosis and therapy of prostrate and colon cancer |
| 09/20/2011 | CA2217522C Isolated frpb nucleic acid molecule and vaccine |
| 09/20/2011 | CA2183542C Methods and compositions for stimulating bone cells |
| 09/15/2011 | WO2011111832A1 Method for selecting polypeptide sequence, metal oxide or silicon containing compound binding peptide and use thereof |
| 09/15/2011 | WO2011111393A1 Fc binding protein and method for producing same |
| 09/15/2011 | US20110224415 Human muty |
| 09/15/2011 | US20110224153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders |
| 09/15/2011 | US20110224102 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 09/15/2011 | US20110224097 Viable gram negative bacteria lacking outer membrane agonists of tlr4/md-2 |
| 09/15/2011 | US20110223686 Protein production method, fusion protein, and antiserum |
| 09/15/2011 | US20110223658 Monoclonal antibodies with enhanced adcc function |
| 09/15/2011 | US20110223636 Fluorescent protein and chromoprotein |
| 09/15/2011 | US20110223635 Method and Composition for Controlling Gene Expression |
| 09/15/2011 | US20110223634 Transfection kinetics and structural promoters |
| 09/15/2011 | US20110223633 Methods and reagents for enrichment and characterization of phosphorylated biomolecules |
| 09/15/2011 | US20110223615 Rapid Expression Cloning of Human Monoclonal Antibodies from Memory B Cells |
| 09/15/2011 | US20110223284 Compositions and Methods for Producing Fermentation Products and Residuals |
| 09/15/2011 | US20110223185 Chimeric hepatitis c virus antigens for eliciting an immune response |
| 09/15/2011 | US20110223165 Humanized C-Kit Antibody |
| 09/15/2011 | US20110223160 Compositions and methods relating to glucagon receptor antibodies |
| 09/15/2011 | US20110223155 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 09/15/2011 | CA2791697A1 Viable gram negative bacteria lacking outer membrane agonists of tlr4/md-2 |
| 09/14/2011 | EP2365090A1 Method for enhancing production of isoprenoid compounds |
| 09/14/2011 | EP2365089A1 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast |
| 09/14/2011 | EP2365085A1 Growth hormone fusion protein |
| 09/14/2011 | EP2365081A2 13 Transmembrane protein expressed in prostate cancer |
| 09/14/2011 | EP2365076A1 Artificial ubiquitous chromatin opening elements (ucoe) |
| 09/14/2011 | EP2365068A2 Enzymes for starch processing |
| 09/14/2011 | EP2365062A1 Rapid production of monoclonal antibodies |
| 09/14/2011 | EP2365004A2 Membrane associated tumor endothelium markers |
| 09/14/2011 | EP2364999A2 Dual-specific ligand and its use |
| 09/14/2011 | EP2364997A2 Polypeptide variants with altered effector function |
| 09/14/2011 | EP2364994A1 Purfied primate CTLA-8 antigens and related reagents |